News Breaks |
|
|
| September 10, 2012 |
| 07:03 EDT |  | CGEN | Compugen announces pre-clinical findings of CGEN-15001
Compugen Ltd. announced that pre-clinical findings presented at the 3rd European Congress of Immunology provide additional support for the potential of CGEN-15001 to effectively treat autoimmune disease. Mode of action studies for CGEN-15001 demonstrated both the active suppression of pathogenic immune responses and the reestablishment of immune balance by increasing anti-inflammatory mediators and promoting inducible regulatory T cells. Modulation of iTregs is considered an extremely promising approach for treatment of autoimmunity and cancer, and therefore has been the focus of intense industry and academic research in recent years. |
|
|
News For CGEN From The Last 14 Days Check below for free stories on CGEN the last two weeks. |
|
|
| There are no results for CGEN |
|
|
|
|
